Introduction

Cloxazolam is a benzodiazepine derivative that has anxiolytic, sedative, and anticonvulsant properties.

Background

It is not widely used; as of August 2018 it was marketed in Belgium, Luxembourg, Portugal, Brazil, and Japan. In 2019, it has been retired from the Belgian market.